The implementation of strict regulations and policies regarding blood contamination is pushing up the demand for blood screening technologies across the globe. As per the World Health Organization (WHO), 123 countries implemented regulations regarding coordinated blood collection, processing, testing, distribution, and storage, whereas, 104 nations enacted specific regulations pertaining to the safety of blood transfusion and the quality of the transfused blood. Furthermore, the increasing number of blood donations is fueling the worldwide demand for blood screening.
As per the WHO, 117.4 million units of blood are donated all over the world every year. Out of this, 100 million units are collected at as many as 12,700 centers in 170 countries. Besides this, the rising prevalence of chronic diseases and the rapid technological advancements being made in the screening technology are also propelling the demand for blood screening solutions around the world, which is, in turn, driving the expansion of the global blood screening market.
This will be because these products are used during the first stage of the blood screening process. Additionally, with the surging usage of reagents and kits for the effective and rapid detection of various transfusion-transmissible diseases (TTD), the requirement for these products is rising sharply. The most widely used technologies for blood screening are the nucleic acid technology (NAT), enzyme-linked immunosorbent assay (ELISA), rapid testing, western blotting, and next-generation sequencing (NGS).
Browse report overview and detailed TOC on: Blood Screening Market Outlook
Across the globe, the demand for blood screening solutions is expected to surge in the Asia-Pacific (APAC) region in the upcoming years. This will be because of the presence of several leading market players, the availability of cost-effective labor, and the rising incidence of various chronic diseases such as cancer in the region. For example, according to the Global Cancer Observatory (GLOBOCAN), 2,003,789 new cancer cases were reported in Southeast Asia in 2018.
